Psychedelic Bulletin #127: Psilocybin Shows Promise in Bipolar Disorder; Gilgamesh Raises $39m; California Decrim. Bill Returns; Canadian Province Covers Cost of PAT

This Week: COMP360 Psilocybin Therapy Shows Promise in Bipolar Disorder, Largely Neglected by Psychedelic Renaissance Gilgamesh Pharmaceuticals Closes $39m Series B California Psychedelic Decrim. Bill Returns Canadian Province Covers Cost of Psilocybin-Assisted Psychotherapy and lots more… COMP360 Psilocybin Therapy Shows Promise in Bipolar Disorder, Largely Neglected by Psychedelic Renaissance…

Source